NASDAQ:KOD

Kodiak Sciences Stock Insider Trading

Healthcare > Biotechnology

Buy KOD

*Your capital is at risk

$33.87

+0.655 (+1.97%)

At Close: Jun 03, 2026

Kodiak Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.21. In total, the insiders bought 9.18M and sold 54.04K KOD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	94.21
● Buy	9.18M shares
● Sell	54.04K shares
83% Buy Activity Weak Positive Correlation
Sell Signal Low Confidence Apr 02, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 94.21. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 15, 2026 Buy	Common Stock M-Exempt	Borgeson John A. Chief Financial Officer	C-Suite Officer	28 614 Value: $29.8K
Apr 15, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Borgeson John A. Chief Financial Officer	C-Suite Officer	28 614 Value: $29.8K
Apr 02, 2026 Sell	Common Stock S-Sale	Borgeson John A. Chief Financial Officer	C-Suite Officer	600 Value: $25.1K
Apr 02, 2026 Sell	Common Stock S-Sale	Borgeson John A. Chief Financial Officer	C-Suite Officer	4 231 Value: $173.0K
Apr 02, 2026 Sell	Common Stock S-Sale	Borgeson John A. Chief Financial Officer	C-Suite Officer	12 477 Value: $502.7K
Apr 02, 2026 Sell	Common Stock S-Sale	Borgeson John A. Chief Financial Officer	C-Suite Officer	12 692 Value: $496.8K
Apr 02, 2026 Buy	Common Stock M-Exempt	Borgeson John A. Chief Financial Officer	C-Suite Officer	30 000 Value: $31.2K
Apr 02, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Borgeson John A. Chief Financial Officer	C-Suite Officer	30 000 Value: $31.2K
Mar 25, 2026 Buy	Common Stock M-Exempt	Perlroth Victor Chairman And CEO	CEO / President	300 000 Value: $312.0K
Mar 25, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Perlroth Victor Chairman And CEO	CEO / President	300 000 Value: $312.0K
Mar 18, 2026 Buy	Stock Option (Right to Buy) A-Award	Perlroth Victor Chairman And CEO	CEO / President	175 000 Value: $4.38M
Dec 31, 2025 Buy	Common Stock J-Other	Perlroth Victor Insider	Other	0 Value: $0
Dec 18, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp	Director	2 391 268 Value: $55.0M
Dec 18, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp	Director	217 428 Value: $5.00M
Jul 04, 2025 Buy	Stock Option (Right to Buy) A-Award	Borgeson John A. See Remarks	Officer	250 000 Value: $987.5K
Jul 04, 2025 Buy	Stock Option (Right to Buy) A-Award	Perlroth Victor Chairman And CEO	CEO / President	340 000 Value: $1.34M
Jul 04, 2025 Buy	Stock Option (Right to Buy) A-Award	Perlroth Victor Chairman And CEO	CEO / President	340 000 Value: $1.34M
Jul 04, 2025 Buy	Stock Option (Right to Buy) A-Award	Borgeson John A. See Remarks	Officer	250 000 Value: $987.5K
Jun 30, 2025 Buy	Non- Qualified Stock Options (right to buy) A-Award	Baker Bros. Advisors Lp	Director	40 000 Value: $149.2K
Jun 30, 2025 Buy	Stock Option (Right to Buy) A-Award	Profusek Robert Director	Director	40 000 Value: $149.2K
Jun 30, 2025 Buy	Stock Option (Right to Buy) A-Award	Yang Taiyin Director	Director	40 000 Value: $149.2K
Jun 30, 2025 Buy	Stock Option (Right to Buy) A-Award	Levy Richard S Director	Director	40 000 Value: $149.2K
Jun 30, 2025 Buy	Stock Option (Right to Buy) A-Award	Bancroft Charles A Director	Director	40 000 Value: $149.2K
Jun 30, 2025 Buy	Stock Option (Right to Buy) A-Award	Dahiyat Bassil I Director	Director	40 000 Value: $149.2K
Jun 30, 2025 Buy	Stock Option (Right to Buy) A-Award	Profusek Robert Director	Director	40 000 Value: $149.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT KODIAK SCIENCES INC.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, ...

Read Full Profile Here